Summary
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
According to APO Research, The global Organoids market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Organoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Organoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Organoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Organoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Organoids include Thermo Fisher Scientific, Merck, Corning, STEMCELL Technologies, Lonza, Prellis Biologics, amsbio, Cellesce and DefiniGEN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Organoids, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Organoids, also provides the revenue of main regions and countries. Of the upcoming market potential for Organoids, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Organoids revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Organoids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Organoids revenue, projected growth trends, production technology, application and end-user industry.
Organoids segment by Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Cellesce
DefiniGEN
OcellO B.V.
HUB Oranoid Technology
3Dnamics Inc.
Organoid Therapeutics
InSphero
Organoids segment by Type
3D Organoid Culture
Biochemical Cues
Organoids segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Organoids segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Organoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Organoids company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organoids revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Organoids Market by Type
1.2.1 Global Organoids Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 3D Organoid Culture
1.2.3 Biochemical Cues
1.3 Organoids Market by Application
1.3.1 Global Organoids Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Research Organizations
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Organoids Market Dynamics
2.1 Organoids Industry Trends
2.2 Organoids Industry Drivers
2.3 Organoids Industry Opportunities and Challenges
2.4 Organoids Industry Restraints
3 Global Growth Perspective
3.1 Global Organoids Market Perspective (2019-2030)
3.2 Global Organoids Growth Trends by Region
3.2.1 Global Organoids Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Organoids Market Size by Region (2019-2024)
3.2.3 Global Organoids Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Organoids Revenue by Players
4.1.1 Global Organoids Revenue by Players (2019-2024)
4.1.2 Global Organoids Revenue Market Share by Players (2019-2024)
4.1.3 Global Organoids Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Organoids Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Organoids Key Players Headquarters & Area Served
4.4 Global Organoids Players, Product Type & Application
4.5 Global Organoids Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Organoids Market CR5 and HHI
4.6.2 Global Top 5 and 10 Organoids Players Market Share by Revenue in 2023
4.6.3 2023 Organoids Tier 1, Tier 2, and Tier 3
5 Organoids Market Size by Type
5.1 Global Organoids Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Organoids Revenue by Type (2019-2030)
5.3 Global Organoids Revenue Market Share by Type (2019-2030)
6 Organoids Market Size by Application
6.1 Global Organoids Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Organoids Revenue by Application (2019-2030)
6.3 Global Organoids Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Comapny Information
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Organoids Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Organoids Product Portfolio
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck
7.2.1 Merck Comapny Information
7.2.2 Merck Business Overview
7.2.3 Merck Organoids Revenue and Gross Margin (2019-2024)
7.2.4 Merck Organoids Product Portfolio
7.2.5 Merck Recent Developments
7.3 Corning
7.3.1 Corning Comapny Information
7.3.2 Corning Business Overview
7.3.3 Corning Organoids Revenue and Gross Margin (2019-2024)
7.3.4 Corning Organoids Product Portfolio
7.3.5 Corning Recent Developments
7.4 STEMCELL Technologies
7.4.1 STEMCELL Technologies Comapny Information
7.4.2 STEMCELL Technologies Business Overview
7.4.3 STEMCELL Technologies Organoids Revenue and Gross Margin (2019-2024)
7.4.4 STEMCELL Technologies Organoids Product Portfolio
7.4.5 STEMCELL Technologies Recent Developments
7.5 Lonza
7.5.1 Lonza Comapny Information
7.5.2 Lonza Business Overview
7.5.3 Lonza Organoids Revenue and Gross Margin (2019-2024)
7.5.4 Lonza Organoids Product Portfolio
7.5.5 Lonza Recent Developments
7.6 Prellis Biologics
7.6.1 Prellis Biologics Comapny Information
7.6.2 Prellis Biologics Business Overview
7.6.3 Prellis Biologics Organoids Revenue and Gross Margin (2019-2024)
7.6.4 Prellis Biologics Organoids Product Portfolio
7.6.5 Prellis Biologics Recent Developments
7.7 amsbio
7.7.1 amsbio Comapny Information
7.7.2 amsbio Business Overview
7.7.3 amsbio Organoids Revenue and Gross Margin (2019-2024)
7.7.4 amsbio Organoids Product Portfolio
7.7.5 amsbio Recent Developments
7.8 Cellesce
7.8.1 Cellesce Comapny Information
7.8.2 Cellesce Business Overview
7.8.3 Cellesce Organoids Revenue and Gross Margin (2019-2024)
7.8.4 Cellesce Organoids Product Portfolio
7.8.5 Cellesce Recent Developments
7.9 DefiniGEN
7.9.1 DefiniGEN Comapny Information
7.9.2 DefiniGEN Business Overview
7.9.3 DefiniGEN Organoids Revenue and Gross Margin (2019-2024)
7.9.4 DefiniGEN Organoids Product Portfolio
7.9.5 DefiniGEN Recent Developments
7.10 OcellO B.V.
7.10.1 OcellO B.V. Comapny Information
7.10.2 OcellO B.V. Business Overview
7.10.3 OcellO B.V. Organoids Revenue and Gross Margin (2019-2024)
7.10.4 OcellO B.V. Organoids Product Portfolio
7.10.5 OcellO B.V. Recent Developments
7.11 HUB Oranoid Technology
7.11.1 HUB Oranoid Technology Comapny Information
7.11.2 HUB Oranoid Technology Business Overview
7.11.3 HUB Oranoid Technology Organoids Revenue and Gross Margin (2019-2024)
7.11.4 HUB Oranoid Technology Organoids Product Portfolio
7.11.5 HUB Oranoid Technology Recent Developments
7.12 3Dnamics Inc.
7.12.1 3Dnamics Inc. Comapny Information
7.12.2 3Dnamics Inc. Business Overview
7.12.3 3Dnamics Inc. Organoids Revenue and Gross Margin (2019-2024)
7.12.4 3Dnamics Inc. Organoids Product Portfolio
7.12.5 3Dnamics Inc. Recent Developments
7.13 Organoid Therapeutics
7.13.1 Organoid Therapeutics Comapny Information
7.13.2 Organoid Therapeutics Business Overview
7.13.3 Organoid Therapeutics Organoids Revenue and Gross Margin (2019-2024)
7.13.4 Organoid Therapeutics Organoids Product Portfolio
7.13.5 Organoid Therapeutics Recent Developments
7.14 InSphero
7.14.1 InSphero Comapny Information
7.14.2 InSphero Business Overview
7.14.3 InSphero Organoids Revenue and Gross Margin (2019-2024)
7.14.4 InSphero Organoids Product Portfolio
7.14.5 InSphero Recent Developments
8 North America
8.1 North America Organoids Revenue (2019-2030)
8.2 North America Organoids Revenue by Type (2019-2030)
8.2.1 North America Organoids Revenue by Type (2019-2024)
8.2.2 North America Organoids Revenue by Type (2025-2030)
8.3 North America Organoids Revenue Share by Type (2019-2030)
8.4 North America Organoids Revenue by Application (2019-2030)
8.4.1 North America Organoids Revenue by Application (2019-2024)
8.4.2 North America Organoids Revenue by Application (2025-2030)
8.5 North America Organoids Revenue Share by Application (2019-2030)
8.6 North America Organoids Revenue by Country
8.6.1 North America Organoids Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Organoids Revenue by Country (2019-2024)
8.6.3 North America Organoids Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Organoids Revenue (2019-2030)
9.2 Europe Organoids Revenue by Type (2019-2030)
9.2.1 Europe Organoids Revenue by Type (2019-2024)
9.2.2 Europe Organoids Revenue by Type (2025-2030)
9.3 Europe Organoids Revenue Share by Type (2019-2030)
9.4 Europe Organoids Revenue by Application (2019-2030)
9.4.1 Europe Organoids Revenue by Application (2019-2024)
9.4.2 Europe Organoids Revenue by Application (2025-2030)
9.5 Europe Organoids Revenue Share by Application (2019-2030)
9.6 Europe Organoids Revenue by Country
9.6.1 Europe Organoids Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Organoids Revenue by Country (2019-2024)
9.6.3 Europe Organoids Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Organoids Revenue (2019-2030)
10.2 China Organoids Revenue by Type (2019-2030)
10.2.1 China Organoids Revenue by Type (2019-2024)
10.2.2 China Organoids Revenue by Type (2025-2030)
10.3 China Organoids Revenue Share by Type (2019-2030)
10.4 China Organoids Revenue by Application (2019-2030)
10.4.1 China Organoids Revenue by Application (2019-2024)
10.4.2 China Organoids Revenue by Application (2025-2030)
10.5 China Organoids Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Organoids Revenue (2019-2030)
11.2 Asia Organoids Revenue by Type (2019-2030)
11.2.1 Asia Organoids Revenue by Type (2019-2024)
11.2.2 Asia Organoids Revenue by Type (2025-2030)
11.3 Asia Organoids Revenue Share by Type (2019-2030)
11.4 Asia Organoids Revenue by Application (2019-2030)
11.4.1 Asia Organoids Revenue by Application (2019-2024)
11.4.2 Asia Organoids Revenue by Application (2025-2030)
11.5 Asia Organoids Revenue Share by Application (2019-2030)
11.6 Asia Organoids Revenue by Country
11.6.1 Asia Organoids Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Organoids Revenue by Country (2019-2024)
11.6.3 Asia Organoids Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Organoids Revenue (2019-2030)
12.2 MEALA Organoids Revenue by Type (2019-2030)
12.2.1 MEALA Organoids Revenue by Type (2019-2024)
12.2.2 MEALA Organoids Revenue by Type (2025-2030)
12.3 MEALA Organoids Revenue Share by Type (2019-2030)
12.4 MEALA Organoids Revenue by Application (2019-2030)
12.4.1 MEALA Organoids Revenue by Application (2019-2024)
12.4.2 MEALA Organoids Revenue by Application (2025-2030)
12.5 MEALA Organoids Revenue Share by Application (2019-2030)
12.6 MEALA Organoids Revenue by Country
12.6.1 MEALA Organoids Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Organoids Revenue by Country (2019-2024)
12.6.3 MEALA Organoids Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Organoids Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. 3D Organoid Culture Major Manufacturers
Table 2. Biochemical Cues Major Manufacturers
Table 3. Global Organoids Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Biopharmaceutical Companies Major Manufacturers
Table 5. Contract Research Organizations Major Manufacturers
Table 6. Academics and Research Institutes Major Manufacturers
Table 7. Organoids Industry Trends
Table 8. Organoids Industry Drivers
Table 9. Organoids Industry Opportunities and Challenges
Table 10. Organoids Industry Restraints
Table 11. Global Organoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Organoids Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Organoids Market Share by Region (2019-2024)
Table 14. Global Organoids Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Organoids Market Share by Region (2025-2030)
Table 16. Global Organoids Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Organoids Revenue Market Share by Players (2019-2024)
Table 18. Global Organoids Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Organoids Key Players Headquarters & Area Served
Table 20. Global Organoids Players, Product Type & Application
Table 21. Global Organoids Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Organoids by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Organoids Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Organoids Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Organoids Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Organoids Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Organoids Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Organoids Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Organoids Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Organoids Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Organoids Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Organoids Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Thermo Fisher Scientific Company Information
Table 35. Thermo Fisher Scientific Business Overview
Table 36. Thermo Fisher Scientific Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Thermo Fisher Scientific Organoids Product Portfolio
Table 38. Thermo Fisher Scientific Recent Development
Table 39. Merck Company Information
Table 40. Merck Business Overview
Table 41. Merck Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Merck Organoids Product Portfolio
Table 43. Merck Recent Development
Table 44. Corning Company Information
Table 45. Corning Business Overview
Table 46. Corning Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Corning Organoids Product Portfolio
Table 48. Corning Recent Development
Table 49. STEMCELL Technologies Company Information
Table 50. STEMCELL Technologies Business Overview
Table 51. STEMCELL Technologies Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. STEMCELL Technologies Organoids Product Portfolio
Table 53. STEMCELL Technologies Recent Development
Table 54. Lonza Company Information
Table 55. Lonza Business Overview
Table 56. Lonza Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Lonza Organoids Product Portfolio
Table 58. Lonza Recent Development
Table 59. Prellis Biologics Company Information
Table 60. Prellis Biologics Business Overview
Table 61. Prellis Biologics Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Prellis Biologics Organoids Product Portfolio
Table 63. Prellis Biologics Recent Development
Table 64. amsbio Company Information
Table 65. amsbio Business Overview
Table 66. amsbio Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. amsbio Organoids Product Portfolio
Table 68. amsbio Recent Development
Table 69. Cellesce Company Information
Table 70. Cellesce Business Overview
Table 71. Cellesce Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Cellesce Organoids Product Portfolio
Table 73. Cellesce Recent Development
Table 74. DefiniGEN Company Information
Table 75. DefiniGEN Business Overview
Table 76. DefiniGEN Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. DefiniGEN Organoids Product Portfolio
Table 78. DefiniGEN Recent Development
Table 79. OcellO B.V. Company Information
Table 80. OcellO B.V. Business Overview
Table 81. OcellO B.V. Organoids Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. OcellO B.V. Organoids Product Portfolio
Table 83. OcellO B.V. Recent Development
Table 84. HUB Oranoid Technology Company Information
Table 85. HUB Oranoid Technology Business Overview
Table 86. HUB Oranoid Technology Organoids Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 87. HUB Oranoid Technology Organoids Product Portfolio
Table 88. HUB Oranoid Technology Recent Development
Table 89. 3Dnamics Inc. Company Information
Table 90. 3Dnamics Inc. Business Overview
Table 91. 3Dnamics Inc. Organoids Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 92. 3Dnamics Inc. Organoids Product Portfolio
Table 93. 3Dnamics Inc. Recent Development
Table 94. Organoid Therapeutics Company Information
Table 95. Organoid Therapeutics Business Overview
Table 96. Organoid Therapeutics Organoids Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 97. Organoid Therapeutics Organoids Product Portfolio
Table 98. Organoid Therapeutics Recent Development
Table 99. InSphero Company Information
Table 100. InSphero Business Overview
Table 101. InSphero Organoids Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 102. InSphero Organoids Product Portfolio
Table 103. InSphero Recent Development
Table 104. North America Organoids Revenue by Type (2019-2024) & (US$ Million)
Table 105. North America Organoids Revenue by Application (2019-2024) & (US$ Million)
Table 106. North America Organoids Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 107. North America Organoids Revenue by Country (2019-2024) & (US$ Million)
Table 108. North America Organoids Revenue by Country (2025-2030) & (US$ Million)
Table 109. Europe Organoids Revenue by Type (2019-2024) & (US$ Million)
Table 110. Europe Organoids Revenue by Application (2019-2024) & (US$ Million)
Table 111. Europe Organoids Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 112. Europe Organoids Revenue by Country (2019-2024) & (US$ Million)
Table 113. Europe Organoids Revenue by Country (2025-2030) & (US$ Million)
Table 114. China Organoids Revenue by Type (2019-2024) & (US$ Million)
Table 115. China Organoids Revenue by Application (2019-2024) & (US$ Million)
Table 116. Asia Organoids Revenue by Type (2019-2024) & (US$ Million)
Table 117. Asia Organoids Revenue by Application (2019-2024) & (US$ Million)
Table 118. Asia Organoids Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. Asia Organoids Revenue by Country (2019-2024) & (US$ Million)
Table 120. Asia Organoids Revenue by Country (2025-2030) & (US$ Million)
Table 121. MEALA Organoids Revenue by Type (2019-2024) & (US$ Million)
Table 122. MEALA Organoids Revenue by Application (2019-2024) & (US$ Million)
Table 123. MEALA Organoids Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 124. MEALA Organoids Revenue by Country (2019-2024) & (US$ Million)
Table 125. MEALA Organoids Revenue by Country (2025-2030) & (US$ Million)
Table 126. Research Programs/Design for This Report
Table 127. Authors List of This Report
Table 128. Secondary Sources
Table 129. Primary Sources
List of Figures
Figure 1. Organoids Product Picture
Figure 2. Global Organoids Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Organoids Market Size Share 2019 VS 2023 VS 2030
Figure 4. 3D Organoid Culture Picture
Figure 5. Biochemical Cues Picture
Figure 6. Global Organoids Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Organoids Market Size Share 2019 VS 2023 VS 2030
Figure 8. Biopharmaceutical Companies Picture
Figure 9. Contract Research Organizations Picture
Figure 10. Academics and Research Institutes Picture
Figure 11. Global Organoids Market Size (US$ Million) & (2019-2030)
Figure 12. Global Organoids Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Organoids Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Organoids Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Organoids Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Organoids Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Organoids Revenue Market Share by Type (2019-2030)
Figure 19. Global Organoids Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Organoids Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Organoids Revenue Market Share by Application (2019-2030)
Figure 22. North America Organoids Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Organoids Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Organoids Revenue Share by Type (2019-2030)
Figure 25. North America Organoids Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Organoids Revenue Share by Application (2019-2030)
Figure 27. North America Organoids Revenue Share by Country (2019-2030)
Figure 28. United States Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Organoids Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Organoids Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Organoids Revenue Share by Type (2019-2030)
Figure 33. Europe Organoids Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Organoids Revenue Share by Application (2019-2030)
Figure 35. Europe Organoids Revenue Share by Country (2019-2030)
Figure 36. Germany Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Organoids Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Organoids Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Organoids Revenue Share by Type (2019-2030)
Figure 45. China Organoids Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Organoids Revenue Share by Application (2019-2030)
Figure 47. Asia Organoids Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Organoids Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Organoids Revenue Share by Type (2019-2030)
Figure 50. Asia Organoids Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Organoids Revenue Share by Application (2019-2030)
Figure 52. Asia Organoids Revenue Share by Country (2019-2030)
Figure 53. Japan Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Organoids Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Organoids Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Organoids Revenue Share by Type (2019-2030)
Figure 62. MEALA Organoids Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Organoids Revenue Share by Application (2019-2030)
Figure 64. MEALA Organoids Revenue Share by Country (2019-2030)
Figure 65. Mexico Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Organoids Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
